David M. Stepien

David M. Stepien

Auto-generated profile, based on publicly available information

David M. Stepien

Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Physiological Reviews
Verified
Journal Article
Open access
PDF file
KIKendra N. Iskander
Kendra N. Iskander
MOMarcin F. Osuchowski
Marcin F. Osuchowski
DSDeborah Stearns-Kurosawa
Deborah Stearns-Kurosawa
SKShinichiro Kurosawa
Shinichiro Kurosawa
DSDavid Stepien
David Stepien
DRDaniel G. Remick
Daniel G. Remick
Sepsis represents the host's systemic inflammatory response to a severe infection. It causes substantial human morbidity resulting in hundreds of thousands of deaths each year. Despite decades of intense research, the basic mechanisms still remain elusive. In either experimental animal models of sepsis or human patients, there are substantial physiological changes, many of which may result in subsequent organ injury. Variations in age, gender, and medical comorbidities including diabetes and renal failure create additional complexity that influence the outcomes in septic patients. Specific system-based alterations, such as the coagulopathy observed in sepsis, offer both potential insight and possible therapeutic targets. Intracellular stress induces changes in the endoplasmic reticulum yielding misfolded proteins that contribute to the underlying pathophysiological changes. With these multiple changes it is difficult to precisely classify an individual's response in sepsis as proinflammatory or immunosuppressed. This heterogeneity also may explain why most therapeutic interventions have not improved survival. Given the complexity of sepsis, biomarkers and mathematical models offer potential guidance once they have been carefully validated. This review discusses each of these important factors to provide a framework for understanding the complex and current challenges of managing the septic patient. Clinical trial failures and the therapeutic interventions that have proven successful are also discussed.

1 October 2013 in Journal of Surgical Research
Verified
Journal Article
Closed access
SYSung H. Yang
Sung H. Yang
JGJosh Gustafson
Josh Gustafson
MGMatt Gangidine
Matt Gangidine
DSDavid Stepien
David Stepien
RSRebecca Schuster
Rebecca Schuster
ALAlex B. Lentsch
Alex B. Lentsch

1 January 2013 in Critical Care Medicine
Verified
Journal Article
Closed access
KIKendra N. Iskander
Kendra N. Iskander
FCFlorin L. Craciun
Florin L. Craciun
DSDavid M. Stepien
David M. Stepien
EDElizabeth R. Ma Duffy
Elizabeth R. Ma Duffy
JKJiyoun Kim
Jiyoun Kim
DRDaniel G. Remick
Daniel G. Remick
Objective: The cause of death in murine models of sepsis remains unclear. The primary purpose of this study was to determine if significant lung injury develops in mice predicted to die after cecal ligation and puncture-induced sepsis compared with those predicted to live. Design: Prospective, laboratory controlled experiments. Setting: University research laboratory. Subjects: Adult, female, outbred Institute of Cancer Research mice. Interventions: Mice underwent cecal ligation and puncture to induce sepsis. Two groups of mice were euthanized at 24 and 48 hrs postcecal ligation and puncture and samples were collected. These mice were further stratified into groups predicted to die (Die-P) and predicted to live (Live-P) based on plasma interleukin-6 levels obtained 24 hrs postcecal ligation and puncture. Multiple measures of lung inflammation and lung injury were quantified in these two groups. Results from a group of mice receiving intratracheal normal saline without surgical intervention were also included as a negative control. As a positive control, bacterial pneumonia was induced with Pseudomonas aeruginosa to cause definitive lung injury. Separate mice were followed for survival until Day 28 postcecal ligation and puncture. These mice were used to verify the interleukin-6 cutoffs for survival prediction. Measurements and Main Results: After sepsis, both the Die-P and Live-P mice had significantly suppressed measures of respiratory physiology but maintained normal levels of arterial oxygen saturation. Bronchoalveolar lavage levels of pro- and anti-inflammatory cytokines were not elevated in the Die-P mice compared with the Live-P. In addition, there was no increase in the recruitment of neutrophils to the lung, pulmonary vascular permeability, or histological evidence of damage. In contrast, all of these pulmonary injury and inflammatory parameters were increased in mice with Pseudomonas pneumonia. Conclusions: These data demonstrate that mice predicted to die during sepsis have no significant lung injury. In murine intra-abdominal sepsis, pulmonary injury cannot be considered the etiology of death in the acute phase.

15 April 2020 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
DSDavid M. Stepien
David M. Stepien
CHCharles Hwang
Charles Hwang
SMSimone Marini
Simone Marini
CPChase A Pagani
Chase A Pagani
MSMichael Sorkin
Michael Sorkin
BLBenjamin Levi
Benjamin Levi
Myeloid cells are critical to the development of fibrosis following muscle injury; however, the mechanism of their role in fibrosis formation remains unclear. In this study, we demonstrate that myeloid cell–derived TGF-β1 signaling is increased in a profibrotic ischemia reperfusion and cardiotoxin muscle injury model. We found that myeloid-specific deletion of Tgfb1 abrogates the fibrotic response in this injury model and reduces fibro/adipogenic progenitor cell proliferation while simultaneously enhancing muscle regeneration, which is abrogated by adaptive transfer of normal macrophages. Similarly, a murine TGFBRII-Fc ligand trap administered after injury significantly reduced muscle fibrosis and improved muscle regeneration. This study ultimately demonstrates that infiltrating myeloid cell TGF-β1 is responsible for the development of traumatic muscle fibrosis, and its blockade offers a promising therapeutic target for preventing muscle fibrosis after ischemic injury. Key Points IRCTX muscle injury results in muscle fibrosis through macrophage-derived TGF-β1. FAPs respond to TGF-β1 by differentiating into fibroblasts. Conditional knockout and systemic inhibition of TGF-β1 attenuates IRCTX fibrosis. Visual Abstract

1 February 2014 in Shock
Verified
Journal Article
Closed access
FCFlorin L. Craciun
Florin L. Craciun
KIKendra N. Iskander
Kendra N. Iskander
ECEvan L. Chiswick
Evan L. Chiswick
DSDavid M. Stepien
David M. Stepien
JHJoel M. Henderson
Joel M. Henderson
DRDaniel G. Remick
Daniel G. Remick
Multiple organ failure in sepsis substantially increases mortality. This study examined if there was greater hepatic, pancreatic, splenic, or renal injury in mice that would die during sepsis induced by cecal ligation and puncture (CLP) compared with that of those that would survive. Mice were stratified into groups predicted to die (Die-P) or predicted to live (Live-P) in the first 5 days after CLP based on plasma interleukin 6 levels. Groups were sacrificed to harvest organs for histology. Separate animals were followed for survival with daily blood sampling to examine renal function. No significant histological evidence of organ injury was observed in either the Live-P or Die-P mice. Minimal hepatic injury occurred as plasma aspartate transaminase demonstrated less than a 2-fold increase over normal in both groups. In addition, pancreatic injury was minimal as there was also less than a 2-fold increase in plasma amylase levels. In contrast, blood urea nitrogen levels were nearly five times higher within 24 h in Die-P mice compared with those of mice predicted to live. Mice with blood urea nitrogen levels higher than 44 mg/dL had a 17.6 higher relative risk of dying (95% confidence interval, 4.5–69.4). Cystatin C, a more specific kidney function biomarker, was also elevated at 24 h after CLP. When the cystatin C levels were analyzed relative to the hours before death, rather than hours after CLP, they were also significantly increased in mice Dead by day 5 compared with those Alive after day 5. We conclude that limited liver, pancreas, and spleen injury develops during murine CLP-induced sepsis while significant kidney injury is present. The renal injury becomes worse closer to death.

1 September 2014 in Critical Care Medicine
Verified
Journal Article
Closed access
SYSung Yang
Sung Yang
DSDavid Stepien
David Stepien
DHDennis Hanseman
Dennis Hanseman
BRBryce Robinson
Bryce Robinson
MGMichael D. Goodman
Michael D. Goodman
ALAlex B. Lentsch
Alex B. Lentsch
Objectives: Traumatic brain injury results in significant morbidity and mortality and is associated with infectious complications, particularly pneumonia. However, whether traumatic brain injury directly impacts the host response to pneumonia is unknown. The objective of this study was to determine the nature of the relationship between traumatic brain injury and the prevalence of pneumonia in trauma patients and investigate the mechanism of this relationship using a murine model of traumatic brain injury with pneumonia. Design: Data from the National Trauma Data Bank and a murine model of traumatic brain injury with postinjury pneumonia. Setting: Academic medical centers in Cincinnati, OH, and Boston, MA. Patients/Subjects: Trauma patients in the National Trauma Data Bank with a hospital length of stay greater than 2 days, age of at least 18 years at admission, and a blunt mechanism of injury. Subjects were female ICR mice 8–10 weeks old. Interventions: Administration of a substance P receptor antagonist in mice. Measurements and Main Results: Pneumonia rates were measured in trauma patients before and after risk adjustment using propensity scoring. In addition, survival and pulmonary inflammation were measured in mice undergoing traumatic brain injury with or without pneumonia. After risk adjustment, we found that traumatic brain injury patients had significantly lower rates of pneumonia compared to blunt trauma patients without traumatic brain injury. A murine model of traumatic brain injury reproduced these clinical findings with mice subjected to traumatic brain injury demonstrating increased bacterial clearance and survival after induction of pneumonia. To determine the mechanisms responsible for this improvement, the substance P receptor was blocked in mice after traumatic brain injury. This treatment abrogated the traumatic brain injury–associated increases in bacterial clearance and survival. Conclusions: The data demonstrate that patients with traumatic brain injury have lower rates of pneumonia compared to non–head-injured trauma patients and suggest that the mechanism of this effect occurs through traumatic brain injury–induced release of substance P, which improves innate immunity to decrease pneumonia.